DERMOVATE Side Effects

5423683-6 | Adrenocortical Insufficiency Acute
on Aug 21, 2007 Male patient from JAPAN , 75 years of age, weighting 105.8 lb, was diagnosed with psoriasis and was treated with Dermovate (View Usage). Patient experienced the following unwanted or unexpected effects: adrenocortical insufficiency acute. Dermovate dosage: . During the same period patient was treated with PROPADERM (View Propaderm Review and Propaderm Label ). Patient was hospitalized.

5034404-3 | Abdominal Pain, Blood Amylase Increased, Blood Creatine Phosphokinase Increased, Blood Glucose Increased, Blood Pressure Increased, C-reactive Protein Increased, Cardiac Arrest, Depressed Level Of Consciousness, Intestinal Obstruction
Patient was taking Dermovate (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), blood amylase increased, blood creatine phosphokinase increased, blood glucose increased, blood pressure increased, c-reactive protein increased, cardiac arrest (What is cardiac arrest?), depressed level of consciousness, intestinal obstruction on Jan 25, 2006 from JAPAN Additional patient health information: Male patient , 50 years of age, weighting 88.18 lb, was diagnosed with psoriasis, pruritus, gastric mucosal lesion and. Dermovate dosage: . During the same period patient was treated with NEORAL (100 Mg/d) (View Neoral Review and Neoral Label ), POLARAMINE (6 Mg/d) (View Polaramine Review and Polaramine Label ), ALLELOCK (10 Mg/d) (View Allelock Review and Allelock Label ), GASTER D (20 Mg/d) (View Gaster D Review and Gaster D Label ). Patient was hospitalized.

4896385-2 | Blood Amylase Increased, Intestinal Obstruction, Pancreatitis
Adverse event was reported on Jan 25, 2006 by a Male patient taking Dermovate (View Usage) (Dosage: ) was diagnosed with psoriasis and. Location: JAPAN , 50 years of age, After Dermovate was administered, patient had the following side effects: blood amylase increased, intestinal obstruction, pancreatitis. During the same period patient was treated with NEORAL (100 Mg/d) (View Neoral Review and Neoral Label ), POLARAMINE (6 Mg/d) (View Polaramine Review and Polaramine Label ), ALLELOCK (10 Mg/d) (View Allelock Review and Allelock Label ), GASTER D (20 Mg/d) (View Gaster D Review and Gaster D Label ). Patient was hospitalized.

4713151-9 | Balance Disorder, Bradyphrenia, Fall, Headache, Hearing Impaired, Sleep Walking
on Jul 07, 2005 Female patient from SWITZERLAND , 83 years of age, was diagnosed with alopecia scarring and was treated with Dermovate (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, bradyphrenia, fall (What is fall?), headache (What is headache?), hearing impaired, sleep walking. Dermovate dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).


4650030-X | Hypotension, Loss Of Consciousness, Shock
on Apr 13, 2005 Female patient from , 73 years of age, was diagnosed with erythema, post procedural pain and was treated with Dermovate (View Usage). Patient had the following side effects: hypotension, loss of consciousness, shock. Dermovate dosage: 1 Df/day. During the same period patient was treated with CLOBETASOL PROPIONATE (0.8 Mg/day) (View Clobetasol Propionate Review and Clobetasol Propionate Label ), DRENISON (0.3 Mg/day) (View Drenison Review and Drenison Label ), DICLOFENAC SODIUM (25 Mg/day) (View Diclofenac Sodium Review and Diclofenac Sodium Label ). Patient was hospitalized.

4640381-7 | Glaucoma
Patient was taking Dermovate (View Usage). After Dermovate was administered, patient had the following side effects: glaucoma (What is glaucoma?) on Jul 06, 2004 from Additional patient health information: Male patient , 29 years of age, was diagnosed with psoriasis and. Dermovate dosage: . During the same period patient was treated with BETNOVAT (View Betnovat Review and Betnovat Label ).

4639104-7 | Shock
Adverse event was reported on Apr 13, 2005 by a Female patient taking Dermovate (View Usage) (Dosage: 1 Df/day) was diagnosed with erythema, post procedural pain and. Location: , 73 years of age, Patient experienced the following unwanted or unexpected effects: shock. During the same period patient was treated with CLOBETASOL PROPIONATE (0.8 Mg/day) (View Clobetasol Propionate Review and Clobetasol Propionate Label ), DRENISON (0.3 Mg/day) (View Drenison Review and Drenison Label ), VOLTAREN (25 Mg/day) (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

4634249-X | Dysgeusia, Erythema, Exanthem, Hypoaesthesia Oral, Malaise, Pruritus, Skin Oedema
on Nov 19, 2004 Female patient from , 52 years of age, weighting 121.3 lb, was diagnosed with nail tinea and was treated with Dermovate (View Usage). Patient had the following side effects: dysgeusia, erythema, exanthem, hypoaesthesia oral, malaise, pruritus, skin oedema. Dermovate dosage: . During the same period patient was treated with LAMISIL (125 Mg/d) (View Lamisil Review and Lamisil Label ).

4610160-5 | Abdominal Distension, Asthenia, Blood Cortisol Decreased, Blood Pressure Increased, Cushing's Syndrome, Erythema, Glaucoma, Hypertension, Intraocular Pressure Increased
on Mar 03, 2005 Male patient from , 74 years of age, was diagnosed with psoriasis, headache (What is headache?), essential hypertension and was treated with Dermovate (View Usage). After Dermovate was administered, patient had the following side effects: abdominal distension, asthenia, blood cortisol decreased, blood pressure increased, cushing's syndrome, erythema, glaucoma (What is glaucoma?), hypertension, intraocular pressure increased. Dermovate dosage: . During the same period patient was treated with CHINESE HERBAL MEDICINE (View Chinese Herbal Medicine Review and Chinese Herbal Medicine Label ), ADVANTAN (View Advantan Review and Advantan Label ), IRBESARTAN (150mg Per Day) (View Irbesartan Review and Irbesartan Label ), DILZEM (180mg Per Day) (View Dilzem Review and Dilzem Label ), PYRALVEX (View Pyralvex Review and Pyralvex Label ), VALIUM (View Valium Review and Valium Label ), NEBILET (View Nebilet Review and Nebilet Label ).

4546284-0 | Depressed Level Of Consciousness, Hyperpyrexia, Hypotension
Patient was taking Dermovate (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, hyperpyrexia, hypotension on Dec 02, 2004 from Additional patient health information: Female patient , 73 years of age, weighting 99.21 lb, was diagnosed with cutaneous lupus erythematosus and. Dermovate dosage: . During the same period patient was treated with VOLTAREN (25mg Per Day) (View Voltaren Review and Voltaren Label ), MYALONE (JAPAN) (View Myalone (japan) Review and Myalone (japan) Label ), DRENISON (1unit Per Day) (View Drenison Review and Drenison Label ).